116 related articles for article (PubMed ID: 33611838)
1. The effects of recombinant klotho in cisplatin-induced ovarian failure in mice.
Biyik I; Ozatik FY; Albayrak M; Ozatik O; Teksen Y; Ari NS; Soysal C
J Obstet Gynaecol Res; 2021 May; 47(5):1817-1824. PubMed ID: 33611838
[TBL] [Abstract][Full Text] [Related]
2. Can Coenzyme Q10 supplementation protect the ovarian reserve against oxidative damage?
Özcan P; Fıçıcıoğlu C; Kizilkale O; Yesiladali M; Tok OE; Ozkan F; Esrefoglu M
J Assist Reprod Genet; 2016 Sep; 33(9):1223-30. PubMed ID: 27255570
[TBL] [Abstract][Full Text] [Related]
3. Can ebselen prevent cisplatin-induced ovarian damage?
Soyman Z; Uzun H; Bayindir N; Esrefoglu M; Boran B
Arch Gynecol Obstet; 2018 Jun; 297(6):1549-1555. PubMed ID: 29600321
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of sildenafil citrate administration on cisplatin-induced ovarian damage in rats.
Taskin MI; Yay A; Adali E; Balcioglu E; Inceboz U
Gynecol Endocrinol; 2015 Apr; 31(4):272-7. PubMed ID: 25483005
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin decreases HOXA13 and alphaVBeta3 integrin levels in the uterus.
Albayrak M; Biyik I; Ozatik FY; Ozatik O; Ari NS; Teksen Y; Erten O
Taiwan J Obstet Gynecol; 2021 Jul; 60(4):728-733. PubMed ID: 34247815
[TBL] [Abstract][Full Text] [Related]
6. Could erythropoietin reduce the ovarian damage of cisplatin in female rats?
Dayangan Sayan C; Tulmac OB; Karaca G; Ozkan ZS; Yalcin S; Devrim T; Dindar Badem N
Gynecol Endocrinol; 2018 Apr; 34(4):309-313. PubMed ID: 29084473
[TBL] [Abstract][Full Text] [Related]
7. Progesterone decreases the extent of ovarian damage caused by cisplatin in an experimental rat model.
Ozdamar S; Taskin MI; Onder GO; Kaymak E; Baran M; Yay A
Adv Clin Exp Med; 2019 Jan; 28(1):25-33. PubMed ID: 30066501
[TBL] [Abstract][Full Text] [Related]
8. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the preventive effects of dehydroepiandrosterone (DHEA) and Caffeic acid phenethyl ester (CAPE) on cisplatin-induced ovarian damage in rats.
Anğın AD; Gün I; Sakin Ö; Çıkman MS; Şimşek EE; Karakuş R; Başak K; Kaptanağası AO
Ultrastruct Pathol; 2020 Jan; 44(1):71-80. PubMed ID: 31909696
[TBL] [Abstract][Full Text] [Related]
10. Zingerone ameliorates cisplatin-induced ovarian and uterine toxicity via suppression of sex hormone imbalances, oxidative stress, inflammation and apoptosis in female wistar rats.
Kaygusuzoglu E; Caglayan C; Kandemir FM; Yıldırım S; Kucukler S; Kılınc MA; Saglam YS
Biomed Pharmacother; 2018 Jun; 102():517-530. PubMed ID: 29587238
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague-Dawley rats.
Özcan P; Fıçıcıoğlu C; Yıldırım ÖK; Özkan F; Akkaya H; Aslan İ
Reprod Biomed Online; 2015 Sep; 31(3):404-10. PubMed ID: 26206282
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of bilberry (Vaccinium myrtillus L.) on cisplatin induced ovarian damage in rat.
Pandir D; Kara O; Kara M
Cytotechnology; 2014 Aug; 66(4):677-85. PubMed ID: 23959170
[TBL] [Abstract][Full Text] [Related]
13. Protective effects and mechanisms investigation of Kuntai capsule on the ovarian function of a novel model with accelerated aging ovaries.
Zhang J; Fang L; Shi L; Lai Z; Lu Z; Xiong J; Wu M; Luo A; Wang S
J Ethnopharmacol; 2017 Jan; 195():173-181. PubMed ID: 27845267
[TBL] [Abstract][Full Text] [Related]
14. The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats.
Li X; Yang S; Lv X; Sun H; Weng J; Liang Y; Zhou D
J Gynecol Oncol; 2013 Apr; 24(2):177-85. PubMed ID: 23653836
[TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of ghrelin and aberrant anti-Mullerian hormone levels in the prevention of ovarian damage caused by cisplatin in Wistar-albino rats.
Tutar EO; Gözüküçük M; Kaya MS; Macun A; Yücel D; Hücümenoğlu S; Çaydere M; Üstün Y
Arch Gynecol Obstet; 2022 Apr; 305(4):1003-1009. PubMed ID: 34687336
[TBL] [Abstract][Full Text] [Related]
16. Protective properties of glycogen synthase kinase-3 inhibition against doxorubicin-induced oxidative damage to mouse ovarian reserve.
Niringiyumukiza JD; Cai H; Chen L; Li Y; Wang L; Zhang M; Xu X; Xiang W
Biomed Pharmacother; 2019 Aug; 116():108963. PubMed ID: 31125824
[TBL] [Abstract][Full Text] [Related]
17. Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats.
Yeh J; Kim BS; Peresie J
Am J Obstet Gynecol; 2008 Apr; 198(4):463.e1-6; discussion 463.e6-7. PubMed ID: 18395042
[TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine leads to greater ovarian protection than enoxaparin sodium in a rat ovarian torsion model.
Sahin Ersoy G; Eken M; Tal R; Oztekin D; Devranoglu B; Isik Kaygusuz E; Cevik O
Reprod Biomed Online; 2016 Jul; 33(1):93-101. PubMed ID: 27083693
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of alpha-lipoic acid in methotrexate-induced ovarian oxidative injury and decreased ovarian reserve in rats.
Soylu Karapinar O; Pinar N; Özcan O; Özgür T; Dolapçıoğlu K
Gynecol Endocrinol; 2017 Aug; 33(8):653-659. PubMed ID: 28361557
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Erythropoietin in Preventing Ischemia-Reperfusion Injury in Ovarian Tissue Transplantation.
Kolusari A; Okyay AG; Koçkaya EA
Reprod Sci; 2018 Mar; 25(3):406-413. PubMed ID: 28655290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
